89 completed, 31 unknown, 30 recruiting, 17 active not recruiting. 200 Phase 3, 31 Phase 2.
Follow Prednisolone: new trials by email Literature Review of Prednisolone trials Research Report on Prednisolone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2027-01-31 | 2026-11-20 |
| A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel in Girls and Women With Female Genital Schistosomiasis Praziquantel 80, Prednisolone, Diclofenac - Female Genital Schistosomiasis | Phase 3 | Not yet recruiting | Brian Ngwira | 800 | 2027-01-01 | 2026-11-04 |
| ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months. Hydroxychloroquine (HCQ), No Hydroxychloroquine (HCQ), Prednisone or Prednisolone - Rheumatic Fever, Rheumatic Heart Disease in Children | Phase 3 | Not yet recruiting | Starship Child Health, Te Toka Tumai Auckland | 600 | 2026-12-01 | 2026-10-07 |
| Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-Thalassemia Thalidomide, Danazol, Prednisolone - Beta-Thalassemia, Thalassemia | Phase 3 | Recruiting | Khyber Medical University Peshawar | 172 | 2026-10-12 | 2026-10-21 |
| A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302] Risvutatug rezetecan (Ris-Rez), Enzalutamide, Abiraterone - Neoplasms, Prostate | Phase 3 | Recruiting | GlaxoSmithKline | 684 | 2026-09-01 | 2026-10-02 |
| Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome Zuberitamab, standard corticosteroid treatment - Nephrotic Syndrome | Phase 3 | Not yet recruiting | Children's Hospital of Fudan University | 120 | 2026-08-20 | 2026-08-14 |
| A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) MK-1045, Rituximab, Rituximab biosimilar - Follicular Lymphoma | Phase 2 / Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 960 | 2026-06-22 | 2026-11-13 |
| Colchicine for Autoimmune and Subacute Thyroiditis colchicine, Prednisolone, NSAID - Hashimoto Thyroiditis, Subacute Thyroiditis | Phase 2 / Phase 3 | Recruiting | Mansoura University | 300 | 2026-06-15 | 2026-07-29 |
| "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis" Prednisolone, Placebo - Hypersensitivity Pneumonitis | Phase 3 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 120 | 2026-06-01 | 2025-10-07 |
| PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis N-Acetylcysteine (NAC) Treatment, Prednisolone, Placebo of N-acetylcysteine - Alcoholic Hepatitis | Phase 3 | Recruiting | University Hospital, Lille | 477 | 2026-05-22 | 2026-06-01 |
| A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer BNT324, Docetaxel, Prednisone/prednisolone - Metastatic Castration-resistant Prostate Cancer | Phase 3 | Recruiting | BioNTech SE | 736 | 2026-04-22 | 2026-11-17 |
| A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer Pasritamig, Docetaxel, Prednisone/Prednisolone - Prostatic Neoplasms, Castration-Resistant | Phase 3 | Recruiting | Janssen Research & Development, LLC | 800 | 2025-12-19 | 2026-11-03 |
| REmission in Membranous Nephropathy International Trial (REMIT) Obinutuzumab, Oral prednisolone and cyclophosphamide - Primary Membranous Nephropathy | Phase 3 | Withdrawn | The University of Queensland | 2025-10-31 | 2025-11-28 | |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation Saruparib, Placebo, Abiraterone + Prednisolone/Prednisone - Prostate Cancer | Phase 3 | Recruiting | AstraZeneca | 700 | 2025-08-06 | 2026-10-14 |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4) Golcadomide, Rituximab, Lenalidomide - Follicular Lymphoma | Phase 3 | Recruiting | Celgene | 400 | 2025-07-28 | 2026-05-20 |
| A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001) Ifinatamab deruxtecan, Docetaxel, Prednisone - Prostate Cancer, Prostatic Neoplasms | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 1440 | 2025-05-13 | 2026-10-30 |
| Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases Bevacizumab, Placebo, Prednisolone - Radionecrosis of Brain, Brain Metastases | Phase 3 | Recruiting | Institut Cancerologie de l'Ouest | 84 | 2025-04-29 | 2025-08-17 |
| Short Course Steroids in Alcohol Associated Hepatitis Prednisolone 40 mg - Alcoholic Hepatitis | Phase 3 | Completed | Asian Institute of Gastroenterology, India | 151 | 2025-04-07 | 2026-09-01 |
| A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer BMS-986365, Enzalutamide, Abiraterone - Metastatic Castration-resistant Prostate Cancer | Phase 3 | Active not recruiting | Celgene | 960 | 2025-03-13 | 2026-09-30 |
| Rituximab in the First Episode of Paediatric Nephrotic Syndrome Rituximab, Corticosteroid - Steroid-Sensitive Nephrotic Syndrome | Phase 3 | Not yet recruiting | Children's Hospital of Fudan University | 138 | 2025-03-01 | 2025-01-22 |
Showing 20 of 200. Sign in to see all of them.
Lymphoma (15) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (13) · Prostatic Neoplasms (13) · Leukemia (9) · Lymphoma, Follicular (9) · Lymphoma, Large B-Cell, Diffuse (9) · Asthma (8) · Lymphoma, Non-Hodgkin (7) · Burkitt Lymphoma (5) · Hepatitis, Alcoholic (5) · Nephrotic Syndrome (5) · Arthritis, Rheumatoid (4) · Aspergillosis, Allergic Bronchopulmonary (4) · Glomerulonephritis, IGA (4) · Hodgkin Disease (4)
Sanofi (8) · GlaxoSmithKline (6) · Merck Sharp & Dohme LLC (6) · Hoffmann-La Roche (5) · Children's Hospital of Fudan University (4) · Children's Oncology Group (4) · EMS (4) · Medical Research Council (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4) · Assistance Publique - Hôpitaux de Paris (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · National Cancer Institute (NCI) (3) · The Hospital for Sick Children (3) · Ain Shams University (2) · All India Institute of Medical Sciences (2)
United Kingdom (54) · United States (52) · Germany (50) · France (45) · Canada (41) · Australia (40) · Italy (37) · Spain (34) · China (32) · Brazil (30) · Netherlands (30) · Poland (29) · Belgium (28) · South Korea (24) · Japan (22)
Birgit Burkhardt, Prof. Dr. Dr. (2) · Daniel TM Chan, Prof (2) · Jack F Wetzels, MD, PhD (2) · Juergen Braun, MD (2) · Qian Shen (2) · Satinder Aneja, MD (2) · A. van Rhenen, MD (1)
PMID 34778952, PMID 35224732, PMID 37505794, PMID 38299639, PMID 41671463, PMID 10820362, PMID 12111109, PMID 12153596, PMID 12239143, PMID 12694250, PMID 12780755, PMID 15353542, PMID 15637138, PMID 15801953, PMID 15952999, PMID 16314615, PMID 17039234, PMID 17132719, PMID 17138821, PMID 17407135, PMID 17475943, PMID 17611565, PMID 17658394, PMID 17658395, PMID 18071116, PMID 18371107, PMID 18493992, PMID 18567886, PMID 18675464, PMID 18990168, PMID 19016733, PMID 19020548, PMID 19132729, PMID 19192962, PMID 19212338, PMID 19228428, PMID 19657114, PMID 19666912, PMID 19731319, PMID 19773418, PMID 19895612, PMID 20007809, PMID 20378563, PMID 20407035, PMID 20459775, PMID 20511662, PMID 20592248, PMID 21106984, PMID 21483000, PMID 21496005
U10CA180886 (6), 2017 (5), 2023 (5), 2025 (4), 2009 (3), 2015 (3), 2014 (2), 2016 (2), 2018 (2), 2004 (1), 2005 (1), 2008 (1), P01CA068484 (1), P30CA006516 (1), P30CA036727 (1)